Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Leo Chandra P. — Monte Rosa Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Leo Chandra P.

Leo Chandra P.

Director at Monte Rosa Therapeutics, Inc. · on record since Jun 25, 2021

Insider trading activity of Leo Chandra P.

Transactions on record: 2; since Jun 25, 2021

Open-market buys: 1; $58.4K

Open-market sells: 0

Companies traded: 1; last filing Mar 25, 2025

Figures computed from official regulatory filings — methodology.

Companies where Leo Chandra P. has traded

Monte Rosa Therapeutics, Inc.2 tx · $58.4K · Mar 25, 2025

Track record of Leo Chandra P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Leo Chandra P.

Co-insiders of Leo Chandra P.

BASKETT FORESTMonte Rosa Therapeutics, Inc.
Behbahani AliMonte Rosa Therapeutics, Inc.
Blackwell KimberlyMonte Rosa Therapeutics, Inc.
Bolzon Bradley J PhDMonte Rosa Therapeutics, Inc.
Bowen MatthewMonte Rosa Therapeutics, Inc.
Castle John C.Monte Rosa Therapeutics, Inc.
Champoux JenniferMonte Rosa Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Chang CarmenMonte Rosa Therapeutics, Inc.

Chen BihuaMonte Rosa Therapeutics, Inc.

Cormorant Asset Management, LPMonte Rosa Therapeutics, Inc.

Cormorant Global Healthcare Master Fund, LPMonte Rosa Therapeutics, Inc.

Cormorant Private Healthcare Fund III LPMonte Rosa Therapeutics, Inc.

Cormorant Private Healthcare Fund II, LPMonte Rosa Therapeutics, Inc.

Dunn EdmundMonte Rosa Therapeutics, Inc.

Florence Anthony A. Jr.Monte Rosa Therapeutics, Inc.

Hughes Eric AMonte Rosa Therapeutics, Inc.

Janku FilipMonte Rosa Therapeutics, Inc.

Jones Julian GMonte Rosa Therapeutics, Inc.

Landsman LizaMonte Rosa Therapeutics, Inc.

Makhzoumi MohamadMonte Rosa Therapeutics, Inc.

MAKOWER JOSHUAMonte Rosa Therapeutics, Inc.

Manning Anthony M.Monte Rosa Therapeutics, Inc.

Mathers Edward TMonte Rosa Therapeutics, Inc.

Mayweg AlexanderMonte Rosa Therapeutics, Inc.

NEA 17 GP, LLCMonte Rosa Therapeutics, Inc.

NEA Partners 17, L.P.Monte Rosa Therapeutics, Inc.

New Enterprise Associates 17, L.P.Monte Rosa Therapeutics, Inc.

Nickson PhilipMonte Rosa Therapeutics, Inc.

SANDELL SCOTT DMonte Rosa Therapeutics, Inc.

SCHIFF ANDREW NMonte Rosa Therapeutics, Inc.

Siu ChristineMonte Rosa Therapeutics, Inc.

Skvarka JanMonte Rosa Therapeutics, Inc.

Sonsini Peter W.Monte Rosa Therapeutics, Inc.

Tamboli AjimMonte Rosa Therapeutics, Inc.

Townson SharonMonte Rosa Therapeutics, Inc.

Versant Vantage I GP-GP, LLCMonte Rosa Therapeutics, Inc.

Versant Vantage I GP, L.P.Monte Rosa Therapeutics, Inc.

Versant Vantage I, L.P.Monte Rosa Therapeutics, Inc.

Versant Venture Capital VI, L.P.Monte Rosa Therapeutics, Inc.

Versant Ventures VI GP-GP, LLCMonte Rosa Therapeutics, Inc.

Versant Ventures VI GP, L.P.Monte Rosa Therapeutics, Inc.

Walker Paul EdwardMonte Rosa Therapeutics, Inc.

Wallace Owen B.Monte Rosa Therapeutics, Inc.

Warmuth MarkusMonte Rosa Therapeutics, Inc.

Yang RickMonte Rosa Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Monte Rosa Therapeutics, Inc.	Mar 25, 2025	Buy	10,000	5.84 USD	$58.4K	SEC
Monte Rosa Therapeutics, Inc.	Jun 25, 2021	AwardD	47,132	0.00 USD	$0	SEC